Neurobiology of Aging
Volume 33, Issue 3 , Pages 437-456 , March 2012

The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE

  • Rita J. Guerreiro

      Affiliations

    • Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD, USA
    • Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal
    • Corresponding Author InformationCorresponding author at. Tel.: 301 435 8866; fax: 301 451 7295
    • ,
  • Deborah R. Gustafson

      Affiliations

    • Neuropsychiatric Epidemiology Unit, Sahlgrenska Academy, University of Gothenburg, Sweden
    • Departments of Neurology and Medicine, SUNY-Downstate Medical Center, Brooklyn, NY, USA
    • ,
  • John Hardy

      Affiliations

    • Reta Lila Weston Institute and Departments of Molecular Neuroscience and Neurodegenerative Disease, Institute of Neurology, London, UK

Received 9 September 2009 ,Revised 1 March 2010 ,Accepted 11 March 2010.

References 

  1. Abraham R, Moskvina V, Sims R, Hollingworth P, Morgan A, Georgieva L, et al. A genome-wide association study for late-onset Alzheimer's disease using DNA pooling . BMC Med Genomics . 2008;1:44
  2. Ahearn JM , Fearon DT . Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21) . Adv Immunol . 1989;46:183–219
  3. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease . Neurobiol Aging . 2000;21:383–421
  4. Altshuler D , Daly MJ , Lander ES . Genetic mapping in human disease . Science . 2008;322:881–888
  5. Ashford JW . APOE genotype effects on Alzheimer's disease onset and epidemiology . J Mol Neurosci . 2004;23:157–165
  6. Ashley-Koch AE, Shao Y, Rimmler JB, Gaskell PC, Welsh-Bohmer KA, Jackson CE, et al. An autosomal genomic screen for dementia in an extended Amish family . Neurosci Lett . 2005;379:199–204
  7. Avramopoulos D , Fallin MD , Bassett SS . Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms . Am J Med Genet B Neuropsychiatr Genet . 2005;132B:9–13
  8. Bacanu SA , Devlin B , Chowdari KV , deKosky ST , Nimgaonkar VL , Sweet RA . Linkage analysis of Alzheimer disease with psychosis . Neurology . 2002;59:118–120
  9. Barrett-Connor E , Edelstein SL , Corey-Bloom J , Wiederholt WC . Weight loss precedes dementia in community-dwelling older adults . J Am Geriatr Soc . 1996;44:1147–1152
  10. Bassett SS , Avramopoulos D , Fallin D . Evidence for parent of origin effect in late-onset Alzheimer disease . Am J Med Genet . 2002;114:679–686
  11. Beecham GW, Martin ER, Li YJ, Slifer MA, Gilbert JR, Haines JL, et al. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease . Am J Hum Genet . 2009;84:35–43
  12. Bekris LM , Galloway NM , Montine TJ , Schellenberg GD , Yu CE . APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure . Am J Med Genet B Neuropsychiatr Genet . 2009;153B(2):409–417
  13. Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R, et al. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system . J Cereb Blood Flow Metab . 2007;27:909–918
  14. Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE . Am J Hum Genet . 2008;83:623–632
  15. Bertram L , McQueen MB , Mullin K , Blacker D , Tanzi RE . Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database . Nat Genet . 2007;39:17–23
  16. Bertram L , Tanzi RE . Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses . Nat Rev Neurosci . 2008;9:768–778
  17. Bertrand P , Poirier J , Oda T , Finch CE , Pasinetti GM . Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease . Brain Res Mol Brain Res . 1995;33:174–178
  18. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families . Hum Mol Genet . 2003;12:23–32
  19. Blom ES, Viswanathan J, Kilander L, Helisalmi S, Soininen H, Lannfelt L, et al. Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease . Eur J Hum Genet . 2008;16:171–175
  20. Bodmer W , Bonilla C . Common and rare variants in multifactorial susceptibility to common diseases . Nat Genet . 2008;40:695–701
  21. Boggs LN, Fuson KS, Baez M, Churgay L, McClure D, Becker G, et al. Clusterin (Apo J) protects against in vitro amyloid-beta (1–40) neurotoxicity . J Neurochem . 1996;67:1324–1327
  22. Bowirrat A , Friedland RP , Chapman J , Korczyn AD . The very high prevalence of AD in an Arab population is not explained by APOE epsilon4 allele frequency . Neurology . 2000;55:731
  23. Bowirrat A , Treves TA , Friedland RP , Korczyn AD . Prevalence of Alzheimer's type dementia in an elderly Arab population . Eur J Neurol . 2001;8:119–123
  24. Bradt BM , Kolb WP , Cooper NR . Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide . J Exp Med . 1998;188:431–438
  25. Buchman AS , Wilson RS , Bienias JL , Shah RC , Evans DA , Bennett DA . Change in body mass index and risk of incident Alzheimer disease . Neurology . 2005;65:892–897
  26. Butler AW, Ng MY, Hamshere ML, Forabosco P, Wroe R, Al-Chalabi A, et al. Meta-analysis of linkage studies for Alzheimer's disease − a web resource . Neurobiol Aging . 2009;30:1037–1047
  27. Cabrejo L, Guyant-Marechal L, Laquerriere A, Vercelletto M, De la Fourniere F, Thomas-Anterion C, et al. Phenotype associated with APP duplication in five families . Brain . 2006;129:2966–2976
  28. Camargos S, Scholz S, Simon-Sanchez J, Paisan-Ruiz C, Lewis P, Hernandez D, et al. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA . Lancet Neurol . 2008;7:207–215
  29. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes . Nat Genet . 1999;22:231–238
  30. Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease . Nat Genet . 2009;41:192–198
  31. Chakravarti A . Population genetics − making sense out of sequence . Nat Genet . 1999;21(suppl):56–60
  32. Chartier-Harlin MC, Parfitt M, Legrain S, Perez-Tur J, Brousseau T, Evans A, et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q132 chromosomal region . Hum Mol Genet . 1994;3:569–574
  33. Choudhry S, Coyle NE, Tang H, Salari K, Lind D, Clark SL, et al. Population stratification confounds genetic association studies among Latinos . Hum Genet . 2006;118:652–664
  34. Clarimon J, Djaldetti R, Lleo A, Guerreiro RJ, Molinuevo JL, Paisan-Ruiz C, et al. Whole genome analysis in a consanguineous family with early onset Alzheimer's disease . Neurobiol Aging . 2008;30:1986–1991 Nos. 12
  35. Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease . J Clin Psychiatry . 2007;68:613–618
  36. Corbo RM , Scacchi R . Apolipoprotein E (APOE) allele distribution in the world (Is APOE* four a “thrifty” allele?) . Ann Hum Genet . 1999;63:301–310
  37. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease . Nat Genet . 1994;7:180–184
  38. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families . Science . 1993;261:921–923
  39. Curtis D , North BV , Sham PC . A novel method of two-locus linkage analysis applied to a genome scan for late onset Alzheimer's disease . Ann Hum Genet . 2001;65:473–481
  40. Danik M , Chabot JG , Hassan-Gonzalez D , Suh M , Quirion R . Localization of sulfated glycoprotein-two/clusterin mRNA in the rat brain by in situ hybridization . J Comp Neurol . 1993;334:209–227
  41. Daw EW, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, et al. The number of trait loci in late-onset Alzheimer disease . Am J Hum Genet . 2000;66:196–204
  42. Dawn Teare M , Barrett JH . Genetic linkage studies . Lancet . 2005;366:1036–1044
  43. de Silva HV , Harmony JA , Stuart WD , Gil CM , Robbins J . Apolipoprotein J: structure and tissue distribution . Biochemistry . 1990;29:5380–5389
  44. De Strooper B . Aph-one, Pen-two, and Nicastrin with Presenilin generate an active gamma-Secretase complex . Neuron . 2003;38:9–12
  45. deMattos RB, Cirrito JR, Parsadanian M, May PC, O'Dell MA, Taylor JW, et al. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo . Neuron . 2004;41:193–202
  46. deMattos RB, O'Dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR, et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease . Proc Natl Acad Sci USA . 2002;99:10843–10848
  47. Devilee P , Cleton-Jansen AM , Cornelisse CJ . Ever since Knudson . Trends Genet . 2001;17:569–573
  48. Di Fede G, Catania M, Morbin M, Rossi G, Suardi S, Mazzoleni G, et al. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis . Science . 2009;323:1473–1477
  49. Duguid JR , Bohmont CW , Liu NG , Tourtellotte WW . Changes in brain gene expression shared by scrapie and Alzheimer disease . Proc Natl Acad Sci USA . 1989;86:7260–7264
  50. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, et al. Cleavage of amyloid beta peptide during constitutive processing of its precursor . Science . 1990;248:1122–1124
  51. Farrer LA , Bowirrat A , Friedland RP , Waraska K , Korczyn AD , Baldwin CT . Identification of multiple loci for Alzheimer disease in a consanguineous Israeli–Arab community . Hum Mol Genet . 2003;12:415–422
  52. Fearnhead NS , Winney B , Bodmer WF . Rare variant hypothesis for multifactorial inheritance: susceptibility to colorectal adenomas as a model . Cell Cycle . 2005;4:521–525
  53. Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SH, Riehle C, et al. Examination of the current top candidate genes for AD in a genome-wide association study . Mol Psychiatry . 2009;
  54. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study . Arch Neurol . 2009;66:336–342
  55. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease . Arch Gen Psychiatry . 2006;63:168–174
  56. Ghiso J, Matsubara E, Koudinov A, Choi-Miura NH, Tomita M, Wisniewski T, et al. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex . Biochem J . 1993;293:27–30
  57. Gibson J , Morton NE , Collins A . Extended tracts of homozygosity in outbred human populations . Hum Mol Genet . 2006;15:789–795
  58. Golabek A , Marques MA , Lalowski M , Wisniewski T . Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid . Neurosci Lett . 1995;191:79–82
  59. Goldstein DB . Common genetic variation and human traits . N Engl J Med . 2009;360:1696–1698
  60. Goossens GH , Blaak EE , van Baak MA . Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders . Obes Rev . 2003;4:43–55
  61. Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A, et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants . Hum Mol Genet . 2007;16:865–873
  62. Guerreiro RJ, Baquero M, Blesa R, Boada M, Bras JM, Bullido MJ, et al. Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP . Neurobiol Aging . 2010;31(5):725–731
  63. Guerreiro RJ, Beck J, Gibbs JR, Santana I, Rossor MN, Schott JM, et al. Genetic Variability in CLU and Its Association with Alzheimer's Disease . PLoS ONE . 2010;5(3):e9510
  64. Gustafson D , Skoog I . Control of vascular risk factors . In:  Wahlund TE ,  Gauthier S editor. Vascular Dementia in Clinical Practice . Cambridge University Press; 2009;
  65. Gustafson D , Rothenberg E , Blennow K , Steen B , Skoog I . An 18-year follow-up of overweight and risk of Alzheimer disease . Arch Intern Med . 2003;163:1524–1528
  66. Gustafson DR, Backman K, Waern M, Ostling S, Guo X, Zandi P, et al. Adiposity indicators and dementia over 32 years in Sweden . Neurology . 2009;73:1559–1566
  67. Gustafson DR , Melchior L , Eriksson E , Sundh V , Blennow K , Skoog I . The ACE Insertion Deletion polymorphism relates to dementia by metabolic phenotype, APOEvarepsilon4, and age of dementia onset . Neurobiol Aging . 2008;31(Nos. 6):910–916
  68. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism . Nature . 1992;359:322–325
  69. Hahs DW, McCauley JL, Crunk AE, McFarland LL, Gaskell PC, Jiang L, et al. A genome-wide linkage analysis of dementia in the Amish . Am J Med Genet B Neuropsychiatr Genet . 2006;141B:160–166
  70. Hammad SM , Ranganathan S , Loukinova E , Twal WO , Argraves WS . Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-two/megalin (A mechanism to prevent pathological accumulation of amyloid beta-peptide) . J Biol Chem . 1997;272:18644–18649
  71. Hamshere ML, Holmans PA, Avramopoulos D, Bassett SS, Blacker D, Bertram L, et al. Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease . Hum Mol Genet . 2007;16:2703–2712
  72. Hardy J . Amyloid, the presenilins and Alzheimer's disease . Trends Neurosci . 1997;20:154–159
  73. Hardy J . The amyloid hypothesis for Alzheimer's disease: a critical reappraisal . J Neurochem . 2009;110:1129–1134
  74. Hardy J , Crook R . Presenilin mutations line up along transmembrane alpha-helices . Neurosci Lett . 2001;306:203–205
  75. Hardy J , Singleton A . Genomewide association studies and human disease . N Engl J Med . 2009;360:1759–1768
  76. Harel A , Wu F , Mattson MP , Morris CM , Yao PJ . Evidence for CALM in directing VAMP2 trafficking . Traffic . 2008;9:417–429
  77. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease . Nat Genet . 2009;41:1088–1093
  78. Hattersley AT , McCarthy MI . What makes a good genetic association study? . Lancet . 2005;366:1315–1323
  79. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study . Alzheimer Dis Assoc Disord . 2006;20:93–100
  80. Henricson A , Kall L , Sonnhammer EL . A novel transmembrane topology of presenilin based on reconciling experimental and computational evidence . FEBS J . 2005;272:2727–2733
  81. Hirschhorn JN . Genomewide association studies − illuminating biologic pathways . N Engl J Med . 2009;360:1699–1701
  82. Hof PR , Glannakopoulos P , Bouras C . The neuropathological changes associated with normal brain aging . Histol Histopathol . 1996;11:1075–1088
  83. Hoglund K , Blennow K . Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease . CNS Drugs . 2007;21:449–462
  84. Hollingworth P, Hamshere ML, Holmans PA, O'Donovan MC, Sims R, Powell J, et al. Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis . Am J Med Genet B Neuropsychiatr Genet . 2007;144B:841–848
  85. Holmans P, Hamshere M, Hollingworth P, Rice F, Tunstall N, Jones S, et al. Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease . Am J Med Genet B Neuropsychiatr Genet . 2005;135B:24–32
  86. Hyman BT , Hedley-Whyte ET , Rebeck GW , Vonsattel JP , West HL , Growdon JH . Apolipoprotein E epsilon4/four in a neuropathologically normal very elderly individual . Arch Neurol . 1996;53:215
  87. International HapMap Consortium . A haplotype map of the human genome . Nature . 2005;437(7063):1299–1320
  88. Ioannidis JP , Ntzani EE , Trikalinos TA , Contopoulos-Ioannidis DG . Replication validity of genetic association studies . Nat Genet . 2001;29:306–309
  89. Jenne DE , Tschopp J . Clusterin: the intriguing guises of a widely expressed glycoprotein . Trends Biochem Sci . 1992;17:154–159
  90. Jones SE , Jomary C . Clusterin . Int J Biochem Cell Biol . 2002;34:427–431
  91. Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men (The Honolulu-Asia aging study) . Arterioscler Thromb Vasc Biol . 2000;20:2255–2260
  92. Kannel WB . Risk stratification in hypertension: new insights from the Framingham Study . Am J Hypertens . 2000;13:3S–10S
  93. Kasuga K, Shimohata T, Nishimura A, Shiga A, Mizuguchi T, Tokunaga J, et al. Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease . J Neurol Neurosurg Psychiatry . 2009;80:1050–1052
  94. Katzov H, Bennet AM, Kehoe P, Wiman B, Gatz M, Blennow K, et al. A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity . Hum Mol Genet . 2004;13:2647–2657
  95. Kauwe JS, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM, et al. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation . Ann Neurol . 2007;61:446–453
  96. Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I, et al. A full genome scan for late onset Alzheimer's disease . Hum Mol Genet . 1999;8:237–245
  97. Kida E , Choi-Miura NH , Wisniewski KE . Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain . Brain Res . 1995;685:211–216
  98. Kim JA , Kim HL . Cell-free expression and functional reconstitution of CALM in clathrin assembly . Exp Mol Med . 2001;33:89–94
  99. Kim M, Suh J, Romano D, Truong MH, Mullin K, Hooli B, et al. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity . Hum Mol Genet . 2009;18:3987–3996
  100. Kivipelto M , Laakso MP , Tuomilehto J , Nissinen A , Soininen H . Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention . CNS Drugs . 2002;16:435–444
  101. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease . Arch Neurol . 2005;62:1556–1560
  102. Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, et al. Alzheimer-associated presenilins one and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells . Nat Med . 1996;2:224–229
  103. Kraft P , Hunter DJ . Genetic risk prediction − are we there yet? . N Engl J Med . 2009;360:1701–1703
  104. Lambert JC, Araria-Goumidi L, Myllykangas L, Ellis C, Wang JC, Bullido MJ, et al. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk . Neurology . 2002;59:59–66
  105. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease . Nat Genet . 2009;41:1094–1099
  106. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-Wide Association Study Identifies Variants at CLU and CR1 Associated With Alzheimer's Disease . Nat Genet . 2009;41(10):1094–1099
  107. Lambert JC, Perez-Tur J, Dupire MJ, Galasko D, Mann D, Amouyel P, et al. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease . Hum Mol Genet . 1997;6:2151–2154
  108. Lander ES . The new genomics: global views of biology . Science . 1996;274:536–539
  109. Lander ES , Botstein D . Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children . Science . 1987;236:1567–1570
  110. Laudon H, Hansson EM, Melen K, Bergman A, Farmery MR, Winblad B, et al. A nine-transmembrane domain topology for presenilin 1 . J. Biol Chem . 2005;280:35352–35360
  111. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study . Neurobiol Aging . 2000;21:49–55
  112. Lee JH , Cheng R , Graff-Radford N , Foroud T , Mayeux R . Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci . Arch Neurol . 2008;65:1518–1526
  113. Lee JH, Cheng R, Santana V, Williamson J, Lantigua R, Medrano M, et al. Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease . Arch Neurol . 2006;63:1591–1598
  114. Lee JH, Mayeux R, Mayo D, Mo J, Santana V, Williamson J, et al. Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics . Mol Psychiatry . 2004;9:1042–1051
  115. Levy-Lahad E, Poorkaj P, Wang K, Fu YH, Oshima J, Mulligan J, et al. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene . Genomics . 1996;34:198–204
  116. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus . Science . 1995;269:973–977
  117. Li G, Shofer JB, Kukull WA, Peskind ER, Tsuang DW, Breitner JC, et al. Serum cholesterol and risk of Alzheimer disease: a community-based cohort study . Neurology . 2005;65:1045–1050
  118. Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease . Arch Neurol . 2008;65:45–53
  119. Li LH, Ho SF, Chen CH, Wei CY, Wong WC, Li LY, et al. Long contiguous stretches of homozygosity in the human genome . Hum Mutat . 2006;27:1115–1121
  120. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, et al. Age at onset in two common neurodegenerative diseases is genetically controlled . Am J Hum Genet . 2002;70:985–993
  121. Liu F, Arias-Vasquez A, Sleegers K, Aulchenko YS, Kayser M, Sanchez-Juan P, et al. A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population . Am J Hum Genet . 2007;81:17–31
  122. Mahley RW . Apolipoprotein E: cholesterol transport protein with expanding role in cell biology . Science . 1988;240:622–630
  123. Mahley RW , Rall SC . Apolipoprotein E: far more than a lipid transport protein . Annu Rev Genomics Hum Genet . 2000;1:507–537
  124. Mani A, Meraji SM, Houshyar R, Radhakrishnan J, Mani A, Ahangar M, et al. Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus . Proc Natl Acad Sci USA . 2002;99:15054–15059
  125. Matsubara E , Soto C , Governale S , Frangione B , Ghiso J . Apolipoprotein J and Alzheimer's amyloid beta solubility . Biochem J . 1996;316:671–679
  126. May PC , Lampert-Etchells M , Johnson SA , Poirier J , Masters JN , Finch CE . Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat . Neuron . 1990;5(6):831–839
  127. McGeer EG , McGeer PL . Innate immunity in Alzheimer's disease: a model for local inflammatory reactions . Mol Interv . 2001;1:22–29
  128. McGeer PL , Akiyama H , Itagaki S , McGeer EG . Activation of the classical complement pathway in brain tissue of Alzheimer patients . Neurosci Lett . 1989;107:341–346
  129. McGeer PL , Kawamata T , Walker DG . Distribution of clusterin in Alzheimer brain tissue . Brain Res . 1992;579:337–341
  130. McGeer PL , Klegeris A , Walker DG , Yasuhara O , McGeer EG . Pathological proteins in senile plaques . Tohoku J Exp Med . 1994;174:269–277
  131. McGeer PL , McGeer EG . The possible role of complement activation in Alzheimer disease . Trends Mol Med . 2002;8:519–523
  132. Michel D , Chatelain G , North S , Brun G . Stress-induced transcription of the clusterin/apoJ gene . Biochem J . 1997;328:45–50
  133. Mielke MM, Zandi PP, Sjogren M, Gustafson D, Ostling S, Steen B, et al. High total cholesterol levels in late life associated with a reduced risk of dementia . Neurology . 2005;64:1689–1695
  134. Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D, et al. Full genome screen for Alzheimer disease: stage II analysis . Am J Med Genet . 2002;114:235–244
  135. Nalls MA, Guerreiro RJ, Simon-Sanchez J, Bras JT, Traynor BJ, Gibbs JR, et al. Extended tracts of homozygosity identify novel candidate genes associated with late-onset Alzheimer's disease . Neurogenetics . 2009;10(Nos. 3):183–190
  136. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease . Neuroepidemiology . 1998;17:14–20
  137. Nuutinen T , Suuronen T , Kauppinen A , Salminen A . Clusterin: A forgotten player in Alzheimer's disease . Brain Res Rev . 2009;61(Nos. 2):89–104
  138. Oda T , Pasinetti GM , Osterburg HH , Anderson C , Johnson SA , Finch CE . Purification and characterization of brain clusterin . Biochem Biophys Res Commun . 1994;204:1131–1136
  139. Oda T, Wals P, Osterburg HH, Johnson SA, Pasinetti GM, Morgan TE, et al. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1–42) and forms slowly sedimenting A beta complexes that cause oxidative stress . Exp Neurol . 1995;136:22–31
  140. Olson JM , Goddard KA , Dudek DM . A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region . Am J Hum Genet . 2002;71:154–161
  141. Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism . Ann Neurol . 2009;65:19–23
  142. Pangalos MN , Jacobsen SJ , Reinhart PH . Disease modifying strategies for the treatment of Alzheimer's disease targeted at modulating levels of the beta-amyloid peptide . Biochem Soc Trans . 2005;33:553–558
  143. Pedersen NL , Posner SF , Gatz M . Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins . Am J Med Genet . 2001;105:724–728
  144. Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, et al. Complete genomic screen in late-onset familial Alzheimer disease (Evidence for a new locus on chromosome 12) . JAMA . 1997;278:1237–1241
  145. Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L, et al. Identification of novel genes in late-onset Alzheimer's disease . Exp Gerontol . 2000;35:1343–1352
  146. Podewils LJ, Guallar E, Kuller LH, Fried LP, Lopez OL, Carlson M, et al. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study . Am J Epidemiol . 2005;161:639–651
  147. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease . Science . 1997;276:2045–2047
  148. Qiu C , Winblad B , Fratiglioni L . The age-dependent relation of blood pressure to cognitive function and dementia . Lancet Neurol . 2005;4:487–499
  149. Rademakers R , Cruts M , Van Broeckhoven C . Genetics of early-onset Alzheimer dementia . Scientific World Journal . 2003;3497–3519
  150. Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T, Foot NJ, et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias . Cancer Res . 2005;65:375–378
  151. Raux G, Guyant-Marechal L, Martin C, Bou J, Penet C, Brice A, et al. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update . J Med Genet . 2005;42:793–795
  152. Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers . Neuron . 2007;54:713–720
  153. Reitz C , Tang MX , Luchsinger J , Mayeux R . Relation of plasma lipids to Alzheimer disease and vascular dementia . Arch Neurol . 2004;61:705–714
  154. Remes AM, Finnila S, Mononen H, Tuominen H, Takalo R, Herva R, et al. Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy . Neurology . 2004;63:234–240
  155. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene . Nature . 1995;376:775–778
  156. Rogaeva E . The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease . Neuromol Med . 2002;2:1–10
  157. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, et al. Complement activation by beta-amyloid in Alzheimer disease . Proc Natl Acad Sci USA . 1992;89:10016–10020
  158. Rovelet-Lecrux A , Frebourg T , Tuominen H , Majamaa K , Campion D , Remes AM . APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage . J Neurol Neurosurg Psychiatry . 2007;78:1158–1159
  159. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy . Nat Genet . 2006;38:24–26
  160. Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils (Isoform apoE4 associates more efficiently than apoE3) . J Clin Invest . 1994;94:860–869
  161. Sayed-Tabatabaei FA , Houwing-Duistermaat JJ , van Duijn CM , Witteman JC . Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis . Stroke . 2003;34:1634–1639
  162. Scott WK, Hauser ER, Schmechel DE, Welsh-Bohmer KA, Small GW, Roses AD, et al. Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22 . Am J Hum Genet . 2003;73:1041–1051
  163. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease . Nature . 1995;375:754–760
  164. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing . Science . 1992;258:126–129
  165. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine . Clin Chem . 1995;41:1068–1086
  166. Sillen A, Andrade J, Lilius L, Forsell C, Axelman K, Odeberg J, et al. Expanded high-resolution genetic study of 109 Swedish families with Alzheimer's disease . Eur J Hum Genet . 2008;16:202–208
  167. Simon-Sanchez J, Scholz S, Fung HC, Matarin M, Hernandez D, Gibbs JR, et al. Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals . Hum Mol Genet . 2007;16:1–14
  168. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease . Nat Genet . 2009;41:1308–1312
  169. Simon-Sanchez J , Singleton A . Genome-wide association studies in neurological disorders . Lancet Neurol . 2008;7:1067–1072
  170. Sjoberg AP , Trouw LA , Blom AM . Complement activation and inhibition: a delicate balance . Trends Immunol . 2009;30:83–90
  171. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia . Lancet . 1996;347:1141–1145
  172. Sleegers K, Brouwers N, Gijselinck I, Theuns J, Goossens D, Wauters J, et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy . Brain . 2006;129:2977–2983
  173. Sparks DL , Scheff SW , Hunsaker JC , Liu H , Landers T , Gross DR . Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol . Exp Neurol . 1994;126:88–94
  174. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk . J Hypertens . 1997;15:1579–1592
  175. Stewart R, Masaki K, Xue QL, Peila R, Petrovitch H, White LR, et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study . Arch Neurol . 2005;62:55–60
  176. Stewart R , White LR , Xue QL , Launer LJ . Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study . Arch Neurol . 2007;64:103–107
  177. Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, White LR, et al. Change in blood pressure and incident dementia: a 32-year prospective study . Hypertension . 2009;54:233–240
  178. Strazzullo P, Iacone R, Iacoviello L, Russo O, Barba G, Russo P, et al. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study . Ann Intern Med . 2003;138:17–23
  179. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, et al  Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype . Exp Neurol . 1994;125:163–171
  180. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease . Proc Natl Acad Sci USA . 1993;90:8098–8102
  181. Strohmeyer R , Shen Y , Rogers J . Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain . Brain Res Mol Brain Res . 2000;81:7–18
  182. Takamaru Y . [Analysis of the 80 kDa antigen in senile plaque amyloid] . Hokkaido Igaku Zasshi . 1994;69:191–201
  183. Takei K , Slepnev VI , Haucke V , De Camilli P . Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis . 1999 May Nat Cell Biol. . 1999;1(1):33–39
  184. Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, et al. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study . Arch Intern Med . 2003;163:1053–1057
  185. Tenner AJ . Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events . Neurobiol Aging . 2001;22:849–861
  186. Tian C , Gregersen PK , Seldin MF . Accounting for ancestry: population substructure and genome-wide association studies . Hum Mol Genet . 2008;17:R143–R150
  187. Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, et al. A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia . Ann Neurol . 2008;63:377–387
  188. Veerhuis R , Janssen I , Hack CE , Eikelenboom P . Early complement components in Alzheimer's disease brains . Acta Neuropathol . 1996;91:53–60
  189. Walker DG , McGeer PL . Complement gene expression in human brain: comparison between normal and Alzheimer disease cases . Brain Res Mol Brain Res . 1992;14:109–116
  190. Webster J, Myers A, Reiman EM, Zismann VL, Joshipura KD, Pearson JV, et al. Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis . Int J Mol Epidemiol Genet . 2009;1:19–30
  191. Webster S , Glabe C , Rogers J . Multivalent binding of complement protein C1Q to the amyloid beta-peptide (A beta) promotes the nucleation phase of A beta aggregation . Biochem Biophys Res Commun . 1995;217:869–875
  192. Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, et al. Molecular and cellular characterization of the membrane attack complex . Alzheimer's Dis Neurobiol Aging . 1997;18:415–421
  193. Weisgraber KH . Apolipoprotein E: structure-function relationships . Adv Protein Chem . 1994;45249–45302
  194. Whitmer RA , Gunderson EP , Quesenberry CP , Zhou J , Yaffe K . Body mass index in midlife and risk of Alzheimer disease and vascular dementia . Curr Alzheimer Res . 2007;4:103–109
  195. Whitmer RA , Gustafson DR , Barrett-Connor E , Haan MN , Gunderson EP , Yaffe K . Central obesity and increased risk of dementia more than three decades later . Neurology . 2008;71:1057–1064
  196. Whitmer RA , Sidney S , Selby J , Johnston SC , Yaffe K . Midlife cardiovascular risk factors and risk of dementia in late life . Neurology . 2005;64:277–281
  197. Wilson MR , Easterbrook-Smith SB . Clusterin is a secreted mammalian chaperone . Trends Biochem Sci . 2000;25:95–98
  198. Wong P, Pineault J, Lakins J, Taillefer D, Leger J, Wang C, et al. Genomic organization and expression of the rat TRPM-two (clusterin) gene, a gene implicated in apoptosis . J Biol Chem . 1993;268:5021–5031
  199. Woods CG , Valente EM , Bond J , Roberts E . A new method for autozygosity mapping using single nucleotide polymorphisms (SNPs) and EXCLUDEAR . J Med Genet . 2004;41:e101
  200. Yoshikai S , Sasaki H , Doh-Ura K , Furuya H , Sakaki Y . Genomic organization of the human amyloid beta-protein precursor gene . Gene . 1990;87:257–263
  201. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study . Neurology . 1995;45:1161–1168
  202. Zannis VI , Just PW , Breslow JL . Human apolipoprotein E isoprotein subclasses are genetically determined . Am J Hum Genet . 1981;33:11–24
  203. Zipfel PF . Complement and Immune Defense: From Innate Immunity to Human Diseases . Immunol Lett . 2009;126:1–7
  204. Zlokovic BV . Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood–brain barrier . Life Sci . 1996;59:1483–1497

PII: S0197-4580(10)00220-4

doi: 10.1016/j.neurobiolaging.2010.03.025

Neurobiology of Aging
Volume 33, Issue 3 , Pages 437-456 , March 2012

Article Tools

* Image Usage & Resolution